Androgens associated with advanced glycation end-products in postmenopausal women

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Menopause

• Publication date

  2010-11-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1097/gme.0b013e3181e170afPMID 20647960
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• The association of endogenous sex hormones, adiposity, and insulin resistance with incident diabetes in postmenopausal women.

  2009cited by this paper
• Sex hormone levels and subclinical atherosclerosis in postmenopausal women: the Multi-Ethnic Study of Atherosclerosis.

  2009cited by this paper
• Cardiovascular risk in menopausal women and prevalent related co-morbid conditions: facing the post-Women's Health Initiative era.

  2009cited by this paper
• Higher serum testosterone concentration in older women is associated with insulin resistance, metabolic syndrome, and cardiovascular disease.

  2009cited by this paper
• Relative androgen excess during the menopausal transition predicts incident metabolic syndrome in midlife women: Study of Women's Health Across the Nation

  2009cited by this paper
• Estrogen replacement therapy in diabetic ovariectomized female rats potentiates postischemic leukocyte adhesion in cerebral venules via a RAGE-related process.

  2009cited by this paper
• Plasma levels of soluble receptor for advanced glycation end products are associated with endothelial function and predict cardiovascular events in nondiabetic patients

  2009cited by this paper
• Mechanisms of Disease: advanced glycation end-products and their receptor in inflammation and diabetes complications

  2008cited by this paper
• Increased serum advanced glycation end‐products is a distinct finding in lean women with polycystic ovary syndrome (PCOS)

  2008cited by this paper
• Oxidative stress: does it play a role in the genesis of early glycated proteins?

  2008cited by this paper
• Postmenopausal women with a history of irregular menses and elevated androgen measurements at high risk for worsening cardiovascular event-free survival: results from the National Institutes of Health--National Heart, Lung, and Blood Institute sponsored Women's Ischemia Syndrome Evaluation.

  2008cited by this paper
• The role of advanced glycation end products in progression and complications of diabetes

  2008cited by this paper
• Androgens in relationship to cardiovascular risk factors in the menopausal transition

  2008cited by this paper
• Role of Androgen Excess on Metabolic Aberrations and Cardiovascular Risk in Women with Polycystic Ovary Syndrome

  2008cited by this paper
• Advanced glycation: a novel outlook on atherosclerosis.

  2007cited by this paper
• Circulating glycotoxins and dietary advanced glycation endproducts: two links to inflammatory response, oxidative stress, and aging.

  2007cited by this paper
• Immunohistochemical localization of advanced glycation end-products (AGEs) and their receptor (RAGE) in polycystic and normal ovaries

  2007cited by this paper
• Reactive oxygen species-induced oxidative stress in the development of insulin resistance and hyperandrogenism in polycystic ovary syndrome.

  2006cited by this paper
• Endogenous sex hormones and risk factors for atherosclerosis in healthy Greek postmenopausal women.

  2006cited by this paper
• Increased levels of serum advanced glycation end‐products in women with polycystic ovary syndrome

  2005cited by this paper
• Diet‐Derived Advanced Glycation End Products Are Major Contributors to the Body's AGE Pool and Induce Inflammation in Healthy Subjects

  2005influential reference
• Human Glycated Albumin Affects Glucose Metabolism in L6 Skeletal Muscle Cells by Impairing Insulin-induced Insulin Receptor Substrate (IRS) Signaling through a Protein Kinase Cα-mediated Mechanism*

  2003cited by this paper
• Endogenous sex hormones and the development of type 2 diabetes in older men and women: the Rancho Bernardo study.

  2002cited by this paper
• Relative androgen excess and increased cardiovascular risk after menopause: a hypothesized relation.

  2001cited by this paper
• Advanced glycation end-products: a review

  2001cited by this paper
• A prospective longitudinal study of serum testosterone, dehydroepiandrosterone sulfate, and sex hormone-binding globulin levels through the menopause transition.

  2000cited by this paper
• Tobacco smoke is a source of toxic reactive glycation products.

  1997influential reference

• Sexual Dysfunction in Diabetic Patients: Τhe Role of Advanced Glycation End Products.

  2023cites this paper
• Evaluation of thyroid dysfunction in different stages of females

  2023cites this paper
• Advanced glycation end-products, cardiac function and heart failure in the general population: The Rotterdam Study

  2022cites this paper
• The Disorders of Endometrial Receptivity in PCOS and Its Mechanisms

  2021cites this paper
• Postmenopausal hyperandrogenism

  2021cites this paper
• Advanced Glycation End Products (AGEs) May Be a Striking Link Between Modern Diet and Health

  2019cites this paper
• Biochemistry of the menopause

  2018cites this paper
• Content Dihydrotestosterone Levels in Postmenopausal Women According to the Comorbid Disease: Type 2 Diabetes and Hypertension

  2017cites this paper
• Discriminating between virilizing ovary tumors and ovary hyperthecosis in postmenopausal women: clinical data, hormonal profiles and image studies.

  2017cites this paper
• Is cardiovascular risk in women with PCOS a real risk? Current insights.

  2017cites this paper
• Lower Serum Levels of Uric Acid in Uterine Fibroids and Fibrocystic Breast Disease Patients in Dongying City, China

  2016cites this paper
• Low testosterone levels are associated with endothelial dysfunction in oophorectomized early postmenopausal women.

  2016cites this paper
• The Endocrine Dyscrasia that Accompanies Menopause and Andropause Induces Aberrant Cell Cycle Signaling that Triggers Cell Cycle Reentry of Post-mitotic Neurons, Neurodysfunction, Neurodegeneration and Cognitive Disease

  2016cites this paper
• The endocrine dyscrasia that accompanies menopause and andropause induces aberrant cell cycle signaling that triggers re-entry of post-mitotic neurons into the cell cycle, neurodysfunction, neurodegeneration and cognitive disease.

  2015cites this paper
• Advanced Glycation End Products: Link between Diet and Ovulatory Dysfunction in PCOS?

  2015cites this paper
• A Unified Hypothesis of Early- and Late-Onset Alzheimer’s Disease Pathogenesis

  2015cites this paper
• A simplified questionnaire for self-assessment of hirsutism in population-based studies.

  2015cites this paper
• Emerging role of advanced glycation-end products (AGEs) in the pathobiology of eye diseases.

  2014cites this paper
• Differential diagnoses of hyperandrogenism in a post menopausal woman

  2014cites this paper
• Menopause Analytical Hormonal Correlate Outcome Study (MAHCOS) and the Association to Brain Electrophysiology (P300) in a Clinical Setting

  2014cites this paper
• Dietary habits and their relationship with hormones and metabolism in overweight and obese women with polycystic ovary syndrome

  2013cites this paper
• Cardiovascular disease among diabetic women with bilateral oophorectomy.

  2013cites this paper
• Preliminary Hormonal Correlations in Female Patients as a Function of Somatic and Neurological Symptom Clusters: An Exploratory Development of a Multi-Hormonal Map for Bio-Identical Replacement Therapy (MHRT)

  2013cites this paper
• –374 T/A Polymorphism in RAGE Gene is Associated with Onset of Diabetes Mellitus, Atherosclerosis, and Renal Dysfunction in Patients with Hypertension

  2013cites this paper
• Crosstalk between advanced glycation and endoplasmic reticulum stress: emerging therapeutic targeting for metabolic diseases.

  2012cites this paper
• Current world literature.

  2012cites this paper
• Circulating androgen levels are associated with subclinical atherosclerosis and arterial stiffness in healthy recently menopausal women.

  2012cites this paper
• How should postmenopausal androgen excess be evaluated?

  2011cites this paper
• Strong and positive association of Endothelin-1 with AGEs in PCOS: A causal relationship or a bystander?

  2011cites this paper
• MECHANISMS IN ENDOCRINOLOGY: Recent advances in cardiovascular aspects of polycystic ovary syndrome

  2011cites this paper
• Strong and positive association of endothelin-1 with AGEs in PCOS: a causal relationship or a bystander?

  2011cites this paper
• Dietary Advanced Glycation End Products and Aging

  2010cites this paper